Frontlight ResearchEarly access
CompletedPhase 1
Study on the investigational drug SAN711, placebo-controlled, administered to healthy adults and elderly subjects at multiple ascending oral doses to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics of SAN711 and its interaction with food
Key facts
- Who runs it
- Saniona A/S
- Where
- Italy1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- Phase
- Phase 1
- People taking part
- 50 people enrolled
- Started
- 12 Feb 2025
- Ended
- 15 Nov 2025
- Type of study
- Interventional
- Record updated
- 8 July 2025
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Can take part
Where is this trial?
It has sites in one country. Choose a country to see its sites.
Data and sources
- Registry record
- Listed on the EU's official list of trials (CTIS).How to verify a trial in the registry
- Record updated
- 8 July 2025